HIL Applied Medical

Ultra-compact Proton Beam Systems for Cancer Therapy

Health Tech & Life Sciences
Non Active, Dec 2023 ceased to operate
Series C Jerusalem Founded 2010
LinkedIn
Total raised
$36.8M
Last: Convertible Debt 2022-07
Stage
Series C
Founded
2010
Headcount
18
HQ
Jerusalem
Sector
Health Tech & Life Sciences

About

HIL Applied Medical is developing ultra-compact, high-performance accelerators for proton therapy. The company applies a patented, laser-based, nanotech-enabled approach to particle acceleration to facilitate cost-effective, single-room proton therapy systems. HIL is also developing ultra-compact beam delivery solutions, specifically beamlines and rotating gantries, that take advantage of the unique properties of laser-accelerated proton beams. With this technology, the company can offer further reductions in the size, cost, and complexity of a complete system. HILs technology aims to enable cost-effective, expandable, add-on single-room solutions while providing clinical capabilities such as 360 rotation, integrated imaging, pencil-beam scanning, IMPT, gating, and adaptive therapy. The companys technology was conceived and incubated at the high-energy physics lab of the Hebrew University in Jerusalem.

Funding history · 5 rounds · $36.8M total

2022-07
Convertible Debt $1.3M
2022-01
Convertible Debt $1.5M
2020-09
Convertible Debt $1.0M
2016-08
Series C $3.7M
2015-01
Series B $1.5M

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesMedical Treatment & Therapeutics
Technologies
Materials & SubstancesNanomaterialsSensingLaserSimulation & Imaging
Target customers
Healthcare & Life SciencesHealthcareProviders
Business model
B2B

Highlights

1 Patents

Tags

cancer-therapytherapeuticsoncologymedical-technologieslasersnanotechnologycancerhospitalsnon-invasiveimagingtreatmentsmedical-deviceschronic-patientsoptronics